STN1010904 ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STN1010904 ophthalmic suspension, covering 2026-08-07 to 2026-08-07. Get the full timeline:
Most recent: Clinical Trial Results: A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) [Phase 2]